BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 17355784)

  • 1. Activated N-formyl peptide receptor and high-affinity IgE receptor occupy common domains for signaling and internalization.
    Xue M; Hsieh G; Raymond-Stintz MA; Pfeiffer J; Roberts D; Steinberg SL; Oliver JM; Prossnitz ER; Lidke DS; Wilson BS
    Mol Biol Cell; 2007 Apr; 18(4):1410-20. PubMed ID: 17267694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of GO-Antisense miRNA-21 on the Expression of Selected Cytokines at Glioblastoma Cell Lines.
    Kutwin M; Sosnowska M; Ostrowska A; Trzaskowski M; Lange A; Wierzbicki M; Jaworski S
    Int J Nanomedicine; 2023; 18():4839-4855. PubMed ID: 37662685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nordy inhibits cell proliferation and angiogenic factor production of malignant human glioma cells mediated by formylpeptide receptor].
    Yao XH; Ping YF; Bian XW; Chen JH; Wang QL; Jiang XF
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(7):479-84. PubMed ID: 17459229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
    Zhou Y; Bian X; Le Y; Gong W; Hu J; Zhang X; Wang L; Iribarren P; Salcedo R; Howard OM; Farrar W; Wang JM
    J Natl Cancer Inst; 2005 Jun; 97(11):823-35. PubMed ID: 15928303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of nordy on FPR function of malignant human glioma cell line U87].
    Chen JH; Bian XW; Yao XH; Yang SX; Xu CR; Zhou XD; Ping YF
    Yao Xue Xue Bao; 2007 Mar; 42(3):257-62. PubMed ID: 17520823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.
    Yao XH; Ping YF; Chen JH; Chen DL; Xu CP; Zheng J; Wang JM; Bian XW
    J Neurooncol; 2008 Jan; 86(1):47-53. PubMed ID: 17611713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
    Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
    Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activation of formylpeptide receptor in human malignant glioma cells and its effects on cell proliferation and production of angiogenic factors].
    Yao XH; Bian XW; Ping YF; Chen JH; Wang QL; Jiang XF
    Ai Zheng; 2007 Mar; 26(3):241-6. PubMed ID: 17355784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologically active peptides interacting with the G protein-coupled formylpeptide receptor.
    Le Y; Wang JM; Liu X; Kong Y; Hou X; Ruan L; Mou H
    Protein Pept Lett; 2007; 14(9):846-53. PubMed ID: 18045224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression.
    Huang J; Chen K; Gong W; Zhou Y; Le Y; Bian X; Wang JM
    Cancer Lett; 2008 Aug; 267(2):254-61. PubMed ID: 18433988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils.
    Cavicchioni G; Fraulini A; Falzarano S; Spisani S
    Bioorg Chem; 2006 Oct; 34(5):298-318. PubMed ID: 16919307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma.
    Liu M; Zhao J; Chen K; Bian X; Wang C; Shi Y; Wang JM
    Int Immunopharmacol; 2012 Nov; 14(3):283-8. PubMed ID: 22863814
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.